Loading...
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
Зохиогч
Sarin, Shiv Kumar
Choudhury, Ashok
Lau, George K.
Zheng, Ming-Hua
Ji, Dong
Abd-Elsalam, Sherief
Hwang, Jaeseok
Qi, Xiaolong
Cua, Ian Homer
Suh, Jeong Ill
Park, Jun Gi
Putcharoen, Opass
Kaewdech, Apichat
Piratvisuth, Teerha
Treeprasertsuk, Sombat
Park, Sooyoung
Wejnaruemarn, Salisa
Payawal, Diana A.
Ahn, Sang Hoon
Yeo, Chang Dong
Alonzo, Uzziel Romar
Chinbayar, Tserendorj
Loho, Imelda M.
Yokosuka, Osamu
Jafri, Wasim
Tan, Soeksiam
Soo, Lau Ing
Tanwandee, Tawesak
Gani, Rino
Anand, Lovkesh
Esmail, Eslam Saber
Khalaf, Mai
Alam, Shahinul
Lin, Chun-Yu
Chuang, Wan-Long
Soin, A. S.
Garg, Hitendra K.
Kalista, Kemal
Batsukh, Badamnachin
Purnomo, Hery Djagat
Dara, Vijay Pal
Rathi, Pravin
Al Mahtab, Mamun
Shukla, Akash
Sharma, Manoj K.
Omata, Masao
APASL COVID Task Force, APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640)
Он
2020 оны есдүгээр сар
Төрөл
journal article
Хэвлэгч
Springer Science and Business Media LLC
Journal
Hepatology International
Volume
14
Issue
5
Start Page
690
End Page
700
ISSN
1936-0533
1936-0541
